Strawbridge, Rebecca
King's College London
16 papers on CoChatORCID 0000-0002-2984-1124
Most cited papers
- Verified
Inflammation and clinical response to treatment in depression: A meta-analysis
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology
Tryptophan and brain disordersTreatment of Major Depression
Cited by 666
- Verified
Peripheral Cytokine Levels and Response to Antidepressant Treatment in Depression: A Systematic Review and Meta-Analysis
Liu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry
Tryptophan and brain disordersTreatment of Major Depression
Cited by 429
- Verified
Biomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment
Treatment of Major DepressionTryptophan and brain disorders
Cited by 415
- Verified
The Human Phenotype Ontology in 2024: phenotypes around the world
Gargano, M. A., Matentzoglu, N., Coleman, B., Addo-Lartey, E. B., Anagnostopoulos, A. V., Anderton, J., Avillach, P., Bagley, A. M., Bakštein, E., Balhoff, J. P., et al. (2024) · Nucleic Acids Research
Biomedical Text Mining and OntologiesGenomics and Rare Diseases
Cited by 410
- Verified
Long-term effects of COVID-19 on mental health: a systematic review
Bourmistrova, N. W., Solomon, T., Braude, P., Strawbridge, R., & Carter, B. (2022) · Journal of Affective Disorders
COVID-19 and Mental HealthLong-Term Effects of COVID-19
Cited by 369
- Verified
Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis
Strawbridge, R., Carter, B., Marwood, L., Bandelow, B., Tsapekos, D., Nikolova, V. L., Taylor, R., Mantingh, T., de Angel, V., Patrick, F., et al. (2019) · British Journal of Psychiatry
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 140
- Verified
Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis
Husain, M. I., Strawbridge, R., Stokes, P. R., & Young, A. H. (2017) · Journal of Psychopharmacology
Treatment of Major DepressionTryptophan and brain disorders
Cited by 139
- Verified
The relationship between cortisol, stress and psychiatric illness: New insights using hair analysis
Herane Vives, A., De Angel, V., Papadopoulos, A., Strawbridge, R., Wise, T., Young, A. H., Arnone, D., & Cleare, A. J. (2015) · Journal of Psychiatric Research
Stress Responses and CortisolAdrenal Hormones and Disorders
Cited by 129
- Verified
Cortisol as a predictor of psychological therapy response in depressive disorders: Systematic review and meta-analysis
Fischer, S., Strawbridge, R., Vives, A. H., & Cleare, A. J. (2017) · British Journal of Psychiatry
Stress Responses and CortisolAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 112
- Verified
Inflammation as a treatment target in mood disorders: review
Jones, B. D. M., Daskalakis, Z. J., Carvalho, A. F., Strawbridge, R., Young, A. H., Mulsant, B. H., & Husain, M. I. (2020) · BJPsych Open
Tryptophan and brain disordersTreatment of Major Depression
Cited by 106
- Verified
Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression
Scott, F., Hampsey, E., Gnanapragasam, S., Carter, B., Marwood, L., Taylor, R. W., Emre, C., Korotkova, L., Martín-Dombrowski, J., Cleare, A. J., et al. (2023) · Journal of Psychopharmacology
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 87
- Verified
Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis
Carter, B., Strawbridge, R., Husain, M. I., Jones, B. D. M., Short, R., Cleare, A. J., Tsapekos, D., Patrick, F., Marwood, L., Taylor, R. W., et al. (2020) · International Review of Psychiatry
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 47
- Verified
Incidence and Nature of Antidepressant Discontinuation Symptoms
Kalfas, M., Tsapekos, D., Butler, M., McCutcheon, R. A., Pillinger, T., Strawbridge, R., Bhat, B. B., Haddad, P. M., Cowen, P. J., Howes, O. D., et al. (2025) · JAMA Psychiatry
Treatment of Major DepressionMental Health Treatment and Access
Cited by 42
- Verified
Long-term symptomatic and functional outcome following an intensive inpatient multidisciplinary intervention for treatment-resistant affective disorders
Wooderson, S. C., Fekadu, A., Markopoulou, K., Rane, L. J., Poon, L., Juruena, M. F., Strawbridge, R., & Cleare, A. J. (2014) · Journal of Affective Disorders
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 22
- Verified
Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients
Hursitoglu, O., Kurutas, E. B., Strawbridge, R., Oner, E., Gungor, M., Tuman, T. C., & Uygur, O. F. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Tryptophan and brain disordersTreatment of Major Depression
Cited by 18
- Verified
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK
Cleare, A. J., Kerr-Gaffney, J., Goldsmith, K., Zenasni, Z., Yaziji, N., Jin, H., Colasanti, A., Geddes, J. R., Kessler, D., McAllister-Williams, R. H., et al. (2025) · The Lancet Psychiatry
Treatment of Major DepressionBipolar Disorder and Treatment
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free